These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 21532625)
21. The RCAS-TVA system for introduction of oncogenes into selected somatic mammary epithelial cells in vivo. Reddy JP; Li Y J Mammary Gland Biol Neoplasia; 2009 Dec; 14(4):405-9. PubMed ID: 19936988 [TBL] [Abstract][Full Text] [Related]
22. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249 [TBL] [Abstract][Full Text] [Related]
23. Hedgehog signaling, keratin 6 induction, and sebaceous gland morphogenesis: implications for pachyonychia congenita and related conditions. Gu LH; Coulombe PA Am J Pathol; 2008 Sep; 173(3):752-61. PubMed ID: 18688029 [TBL] [Abstract][Full Text] [Related]
24. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Luo M; Fan H; Nagy T; Wei H; Wang C; Liu S; Wicha MS; Guan JL Cancer Res; 2009 Jan; 69(2):466-74. PubMed ID: 19147559 [TBL] [Abstract][Full Text] [Related]
25. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473 [TBL] [Abstract][Full Text] [Related]
26. Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system. von Werder A; Seidler B; Schmid RM; Schneider G; Saur D Nat Protoc; 2012 May; 7(6):1167-83. PubMed ID: 22635109 [TBL] [Abstract][Full Text] [Related]
27. A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis. Wang W; Meng Y; Dong B; Dong J; Ittmann MM; Creighton CJ; Lu Y; Zhang H; Shen T; Wang J; Rowley DR; Li Y; Chen F; Moore DD; Yang F Neoplasia; 2017 May; 19(5):421-428. PubMed ID: 28433771 [TBL] [Abstract][Full Text] [Related]
28. IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis. Farabaugh SM; Litzenburger BC; Elangovan A; Pecar G; Walheim L; Atkinson JM; Lee AV Dev Biol; 2020 Jul; 463(1):77-87. PubMed ID: 32376245 [TBL] [Abstract][Full Text] [Related]
29. Lentivirus vectors for stably introducing genes into mammary epithelial cells in vivo. Bu W; Xin L; Toneff M; Li L; Li Y J Mammary Gland Biol Neoplasia; 2009 Dec; 14(4):401-4. PubMed ID: 19936990 [TBL] [Abstract][Full Text] [Related]
30. Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model. Zhang G; Chi Y; Du YN J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155705 [TBL] [Abstract][Full Text] [Related]
31. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523 [TBL] [Abstract][Full Text] [Related]
32. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling. Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747 [TBL] [Abstract][Full Text] [Related]
33. Keratin 6a reorganization for ubiquitin-proteasomal processing is a direct antimicrobial response. Chan JKL; Yuen D; Too PH; Sun Y; Willard B; Man D; Tam C J Cell Biol; 2018 Feb; 217(2):731-744. PubMed ID: 29191848 [TBL] [Abstract][Full Text] [Related]
34. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782 [TBL] [Abstract][Full Text] [Related]
35. Modeling Breast Cancer via an Intraductal Injection of Cre-expressing Adenovirus into the Mouse Mammary Gland. Xiang D; Tao L; Li Z J Vis Exp; 2019 Jun; (148):. PubMed ID: 31233030 [TBL] [Abstract][Full Text] [Related]
36. Development of mammary tumors by conditional expression of GLI1. Fiaschi M; Rozell B; Bergström A; Toftgård R Cancer Res; 2009 Jun; 69(11):4810-7. PubMed ID: 19458072 [TBL] [Abstract][Full Text] [Related]
37. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis. Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284 [TBL] [Abstract][Full Text] [Related]
38. Stem/progenitor cells in mouse mammary gland development and breast cancer. Li Y; Rosen JM J Mammary Gland Biol Neoplasia; 2005 Jan; 10(1):17-24. PubMed ID: 15886883 [TBL] [Abstract][Full Text] [Related]
39. Using the RCAS-TVA system to model human cancer in mice. Ahronian LG; Lewis BC Cold Spring Harb Protoc; 2014 Nov; 2014(11):1128-35. PubMed ID: 25368315 [TBL] [Abstract][Full Text] [Related]
40. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression. Cantrell MA; Ebelt ND; Pfefferle AD; Perou CM; Van Den Berg CL Oncotarget; 2015 May; 6(14):11863-81. PubMed ID: 25970777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]